These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 9873360)

  • 1. Psychometric evaluation of the international prostate symptom score.
    Gray M
    Urol Nurs; 1998 Sep; 18(3):175-83. PubMed ID: 9873360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The validity of the IPSS questionnaire in a sample of 262 patients with benign prostatic hyperplasia].
    Luján Galán M; Páez Borda A; Martín Osés E; Llanes González L; Berenguer Sánchez A
    Arch Esp Urol; 1997 Oct; 50(8):847-53. PubMed ID: 9463282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simple case definition of clinical benign prostatic hyperplasia, based on International Prostate Symptom Score, predicts general practitioner consultation rates.
    Kok ET; Bohnen AM; Jonkheijm R; Gouweloos J; Groeneveld FP; Thomas S; Bosch JL
    Urology; 2006 Oct; 68(4):784-9. PubMed ID: 17070353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of the Mandarin version of the International Prostate Symptom Score inventory in assessing lower urinary tract symptoms in a Malaysian population.
    Quek KF; Chua CB; Razack AH; Low WY; Loh CS
    Int J Urol; 2005 Jan; 12(1):39-45. PubMed ID: 15661053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Validation of a French adaptation of the international prostatic symptom score].
    Grégoire JP; Moisan J; Labrecque M; Cusan L; Diamond P
    Prog Urol; 1996 Apr; 6(2):240-9. PubMed ID: 8777417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study.
    Roehrborn CG; McVary KT; Elion-Mboussa A; Viktrup L
    J Urol; 2008 Oct; 180(4):1228-34. PubMed ID: 18722631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
    Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
    J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A statistical study of the American Urological Association symptom index for benign prostatic hyperplasia in participants of mass screening program for prostatic diseases using transrectal sonography.
    Ukimura O; Kojima M; Inui E; Ochiai A; Hata Y; Watanabe M; Saitoh M; Watanabe H
    J Urol; 1996 Nov; 156(5):1673-8. PubMed ID: 8863568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function.
    Li MK; Garcia L; Patron N; Moh LC; Sundram M; Leungwattanakij S; Pripatnanont C; Cheng C; Chi-Wai M; Loi-Cheong N
    BJU Int; 2008 Jan; 101(2):197-202. PubMed ID: 18005205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of symptoms in patients with benign prostatic hyperplasia].
    Riehmann M; Jønler M; Nordling J; Hald T
    Ugeskr Laeger; 1996 May; 158(20):2853-8. PubMed ID: 8686021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High power diode laser vaporization of the prostate: preliminary results for benign prostatic hyperplasia.
    Erol A; Cam K; Tekin A; Memik O; Coban S; Ozer Y
    J Urol; 2009 Sep; 182(3):1078-82. PubMed ID: 19616811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cultural and linguistic validation of questionnaires for use in international studies: the nine-item BPH-specific quality-of-life scale.
    Boyle P
    Eur Urol; 1997; 32 Suppl 2():50-2. PubMed ID: 9248816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of the International Prostate Symptom Score bother question with the Benign Prostatic Hyperplasia Impact Index in a clinical practice setting.
    O'Leary MP; Wei JT; Roehrborn CG; Miner M;
    BJU Int; 2008 Jun; 101(12):1531-5. PubMed ID: 18445080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Filling and voiding symptoms in the American Urological Association symptom index: the value of their distinction in a Veterans Affairs randomized trial of medical therapy in men with a clinical diagnosis of benign prostatic hyperplasia.
    Barry MJ; Williford WO; Fowler FJ; Jones KM; Lepor H
    J Urol; 2000 Nov; 164(5):1559-64. PubMed ID: 11025704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emotional care experienced by hospitalised patients: development and testing of a measurement instrument.
    Williams AM; Kristjanson LJ
    J Clin Nurs; 2009 Apr; 18(7):1069-77. PubMed ID: 19077011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive evaluation of bladder and urethral dysfunction symptoms: development and psychometric validation of the Urinary Symptom Profile (USP) questionnaire.
    Haab F; Richard F; Amarenco G; Coloby P; Arnould B; Benmedjahed K; Guillemin I; Grise P
    Urology; 2008 Apr; 71(4):646-56. PubMed ID: 18313122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical impact of tamsulosin on generic and symptom-specific quality of life for benign prostatic hyperplasia patients: using international prostate symptom score and Rand Medical Outcomes Study 36-item Health Survey.
    Suzuki H; Yano M; Awa Y; Nakatsu H; Egoshi K; Mikami K; Ota S; Okano T; Hamano S; Ohki T; Furuya Y; Ichikawa T
    Int J Urol; 2006 Sep; 13(9):1202-6. PubMed ID: 16984553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a quality-of-life scale for Chinese patients with benign prostatic hyperplasia.
    Shi J; Sun Z; Cai T; Yang L
    BJU Int; 2004 Oct; 94(6):837-44. PubMed ID: 15476519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of nocturia in the International Prostate Symptom Score for benign prostatic hyperplasia.
    Homma Y; Yamaguchi T; Kondo Y; Horie S; Takahashi S; Kitamura T
    J Urol; 2002 Jan; 167(1):172-6. PubMed ID: 11743299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reliability and validity of the King's Health Questionnaire for lower urinary tract symptoms in both genders.
    Okamura K; Nojiri Y; Osuga Y
    BJU Int; 2009 Jun; 103(12):1673-8. PubMed ID: 19154505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.